Start

On July 28, the FDA approved a first-time generic formulation for finasteride 1-mg tablets (made by Dr. Reddy’s Laboratories, Ltd; brand name Propecia, made by Merck & Co, Inc).

Finasteride is indicated for the treatment of androgenetic alopecia in men only. Its clinical safety and efficacy have been demonstrated in men aged 18 to 41 years with mild to moderate hair loss of the vertex and anterior mid-scalp areas.

End